Cross Country Healthcare Statistics
Total Valuation
CCRN has a market cap or net worth of $487.92 million. The enterprise value is $410.16 million.
Important Dates
The last earnings date was Wednesday, March 5, 2025, after market close.
Earnings Date | Mar 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CCRN has 32.81 million shares outstanding. The number of shares has decreased by -5.91% in one year.
Current Share Class | 32.81M |
Shares Outstanding | 32.81M |
Shares Change (YoY) | -5.91% |
Shares Change (QoQ) | -2.18% |
Owned by Insiders (%) | 5.97% |
Owned by Institutions (%) | 91.36% |
Float | 28.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 37.23 |
PS Ratio | 0.37 |
Forward PS | 0.38 |
PB Ratio | 1.15 |
P/TBV Ratio | 2.11 |
P/FCF Ratio | 4.38 |
P/OCF Ratio | 4.06 |
PEG Ratio | 3.72 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 33.95, with an EV/FCF ratio of 3.68.
EV / Earnings | n/a |
EV / Sales | 0.31 |
EV / EBITDA | 33.95 |
EV / EBIT | n/a |
EV / FCF | 3.68 |
Financial Position
The company has a current ratio of 2.78, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.78 |
Quick Ratio | 2.63 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.25 |
Debt / FCF | 0.03 |
Interest Coverage | -2.48 |
Financial Efficiency
Return on equity (ROE) is -3.28% and return on invested capital (ROIC) is -0.76%.
Return on Equity (ROE) | -3.28% |
Return on Assets (ROA) | -0.53% |
Return on Invested Capital (ROIC) | -0.76% |
Return on Capital Employed (ROCE) | -1.16% |
Revenue Per Employee | $139,928 |
Profits Per Employee | -$1,515 |
Employee Count | 9,605 |
Asset Turnover | 2.12 |
Inventory Turnover | n/a |
Taxes
Income Tax | -1.84M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.57% in the last 52 weeks. The beta is 0.44, so CCRN's price volatility has been lower than the market average.
Beta (5Y) | 0.44 |
52-Week Price Change | -20.57% |
50-Day Moving Average | 16.91 |
200-Day Moving Average | 15.04 |
Relative Strength Index (RSI) | 22.65 |
Average Volume (20 Days) | 505,419 |
Short Selling Information
The latest short interest is 1.80 million, so 5.47% of the outstanding shares have been sold short.
Short Interest | 1.80M |
Short Previous Month | 2.43M |
Short % of Shares Out | 5.47% |
Short % of Float | 6.29% |
Short Ratio (days to cover) | 2.91 |
Income Statement
In the last 12 months, CCRN had revenue of $1.34 billion and -$14.56 million in losses. Loss per share was -$0.44.
Revenue | 1.34B |
Gross Profit | 274.25M |
Operating Income | -5.42M |
Pretax Income | 16.60M |
Net Income | -14.56M |
EBITDA | 12.08M |
EBIT | -5.42M |
Loss Per Share | -$0.44 |
Full Income Statement Balance Sheet
The company has $81.63 million in cash and $3.87 million in debt, giving a net cash position of $77.76 million or $2.37 per share.
Cash & Cash Equivalents | 81.63M |
Total Debt | 3.87M |
Net Cash | 77.76M |
Net Cash Per Share | $2.37 |
Equity (Book Value) | 418.96M |
Book Value Per Share | 12.98 |
Working Capital | 214.60M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $120.12 million and capital expenditures -$8.71 million, giving a free cash flow of $111.40 million.
Operating Cash Flow | 120.12M |
Capital Expenditures | -8.71M |
Free Cash Flow | 111.40M |
FCF Per Share | $3.40 |
Full Cash Flow Statement Margins
Gross margin is 20.41%, with operating and profit margins of -0.40% and -1.08%.
Gross Margin | 20.41% |
Operating Margin | -0.40% |
Pretax Margin | -1.22% |
Profit Margin | -1.08% |
EBITDA Margin | 0.90% |
EBIT Margin | -0.40% |
FCF Margin | 8.29% |
Dividends & Yields
CCRN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 5.91% |
Shareholder Yield | n/a |
Earnings Yield | -2.98% |
FCF Yield | 22.83% |
Analyst Forecast
The average price target for CCRN is $18.41, which is 23.81% higher than the current price. The consensus rating is "Buy".
Price Target | $18.41 |
Price Target Difference | 23.81% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CCRN has an Altman Z-Score of 5.13 and a Piotroski F-Score of 3.
Altman Z-Score | 5.13 |
Piotroski F-Score | 3 |